Vietnam Health Minister Calls For Greater Drug Industry Regulation
This article was originally published in PharmAsia News
Vietnamese health officials called for more regulation of the country's pharmaceutical industry. In a meeting of local authorities on rising drug prices, some attendees noted Vietnamese drug makers import 90 percent of their raw materials and satisfy only half of the local demand for medicines, most for relatively minor illnesses. Health Minister Nguyen Quoc Trieu, who addressed the conference, said drug prices are high in the country in part because of a lax regulation and bad distribution systems. He called for greater regulation, particularly for specific and rare medicines. (Click here for more
You may also be interested in...
A more conservative US Supreme Court may mean a less authoritative FDA, and drug pricing won’t get as much attention in the presidential campaign, which is a good thing.
The US HHS played defense on 20 September, pushing back on suggestions that secretary Alex Azar’s recent move to exert control over regulations by signing off on them was a power play aimed at the FDA. Meanwhile, former agency head Scott Gottlieb says it’s “the wrong move at the wrong time.”
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?